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Abstract
Objectives Our aim was to compare the quantitative
position of the level descriptors of the standard EQ-5D
three-level system (3L) and a newly developed, experi-
mental five-level version (5L) using a direct and a vignette-
based indirect method.
Methods Eighty-two respondents took part in the study.
The direct method represented a visual analog scale (VAS)
rating of the nonextreme level descriptors for each
dimension and each instrument separately. The indirect
method required respondents to score 15 health scenarios
with 3L, 5L and a VAS scale. Investigated were: (1)
equidistance (Are 3L and 5L level descriptors distributed
evenly over the VAS continuum?); (2) isoformity (Do the
identical level descriptors on 3L and 5L yield similar
results?); and (3) consistency between dimensions (Do the
positions of similar level descriptors differ across dimen-
sions within instruments?).
Results Equidistance without transformation was rejected
for all dimensions for both 3L and 5L but satisfied for 5L
after transformation. Isoformity gave mixed results. Con-
sistency between dimensions was satisfied for both
instruments and both methods.
Discussion The level descriptors have similar distribu-
tions across comparable dimensions within each system,
but the pattern differs between 3L and 5L. This methodo-
logical study provides evidence of increased descriptive
power and a broadened measurement continuum that
encourages the further development of an official five-level
EQ-5D.
Keywords EQ-5D  Methodology  Health-related
quality of life  Psychometrics  Health status
Introduction
The EQ-5D is a widely used instrument to describe and
value generic health (status) in terms of five dimensions:
mobility, self-care, usual activities, pain/discomfort, and
anxiety/depression. Each dimension comprises three levels,
indicating no problems, some or moderate problems, and
extreme problems, resulting in a total of 243 (35) unique
health states [1].
The condensed format of the EQ-5D has undoubtedly
contributed to its global dissemination, as it is easy to
include in existing surveys by questionnaire designers, easy
to fill out by respondents, and easy to report by analysts.
However, compared with other generic preference based
instruments such as the Health Utilities Index Mark 2 and
Mark 3 (HUI2 and HUI3) and the Short Form 6D (SF-6D),
which define respectively 24,000, 972,000, and 18,000
unique health states, the EQ-5D is lacking descriptive
richness [2–5]. Although the EQ-5D descriptive system has
demonstrated strong psychometric properties in general, its
restricted ability to discriminate (clinically relevant) small
to moderate differences in health status between individu-
als or within individuals over time is recognized [6–9].
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Moreover, several studies have reported on the ceiling
effect of the EQ-5D in the general population as well as in
patient populations [10–15].
A straightforward way of improving the discriminatory
potential of the EQ-5D descriptive system is to increase the
number of response options. In most health-status classi-
fication systems, the response options are ordered in terms
of severity along a hypothetical measurement continuum.
Since the exact position of the response options defines the
discriminatory abilities of the descriptive system [16, 17],
it is important to know where on the measurement con-
tinuum the level descriptors are quantitatively positioned.
Previous research in which a five-level (5L) version of
EQ-5D was compared with the standard three-level (3L)
EQ-5D demonstrated increased discriminatory power,
increased reliability, and satisfactory validity [18, 19]. This
paper presents a head-to-head comparison of the quantita-
tive positioning of the level descriptors of the standard 3L
EQ-5D descriptive system versus a newly developed,
experimental 5L system, which covers 3,125 unique health
states (55). Two independent methods were used. The first
method directly compared the nonextreme level descriptors
(for 3L: the level two midcategory; for 5L: the level two,
level three, and level four categories) for each dimension
separately on a visual analogue scale (VAS). The second,
indirect, method required respondents to score complete
health scenarios (vignettes) on dimension-specific VAS
scales and subsequently to classify the same vignettes on
the two EQ-5D instruments (3L and 5L).
Methods
Instruments
Three instruments were used in this study: the standard
EQ-5D3L version, an adapted Dutch 5L version developed
in 1993 [20], and a set of five dimension-specific VAS
scales. The version of the 5L EQ-5D used in this study was
an experimental version, since at the time of this study, no
official five-level version had been advocated by the Eu-
roQol Group. We chose to test a five-level EQ-5D system,
even though we also could have chosen four or six levels.
An increase in the number of levels is always an increase of
discriminatory potential at the cost of a more complex
descriptive system (which might compromise the robust-
ness of the value function). Five levels appears to be an
optimal number of response options concerning reliability
[21, 22]. Furthermore, Preston et al. (2000) investigated
feasibility for 11 different rating formats (ranging from 2 to
11 and a 101 point scale) and found that feasibility peaked
at five levels [23]. We chose to add two in-between levels
to the existing 3L descriptive system (between levels 1 and
2 and levels 2 and 3) because we considered this the most
obvious option in regard to the objective of refining the
EQ-5D instrument. In any preference-based instrument,
level descriptors are practically required for valuation
research in which generic profiles are to be valued. A small
focus group was assigned to determine the wording of the
level descriptors. The level descriptors presented here were
translated from Dutch. The one-, three-, and five-level
descriptors in 5L were the same as the one-, two-, and
three–level descriptors in the standard EQ-5D3L. The
grading terms that were used for the intermediate levels
two and four in the 5L-system were ‘‘a little’’ for level 2
(5L-2) in Anxiety/Depression and ‘‘mild problems’’ for the
remaining dimensions; and ‘‘severe’’ for level 4 (5L-4) in
Pain/Discomfort, ‘‘very’’ for Anxiety/Depression, and
‘‘many problems’’ for the remaining dimensions. One fur-
ther alteration was made to both the 3L and 5L systems: the
most severe response category in Mobility was changed
from ‘‘confined to bed’’ to ‘‘unable to walk about’’, so it
would be analogous to the extreme response categories of
the other dimensions. Table 1 displays the exact wording
of the descriptors in the 3L and 5L systems, respectively.
To obtain quantitative values for each level descriptor of
3L and 5L, the VAS was used. We used five VAS scales,
one for each EQ-5D dimension. Each VAS consisted of a
horizontal hashmarked line without corresponding num-
bers, with the extreme-level descriptors belonging to that
dimension as anchors. Respondents were asked to indicate
their score on the VAS by marking the line. For the most
severe category of Pain/Discomfort and Anxiety/Depres-
sion, the original descriptor was labeled ‘‘extreme’’.
Because the study was part of a larger process of choosing
the definite level descriptors for the official five-level
version of the EQ-5D, we decided to use the entire con-
tinuum of disability (extreme included), and used ‘‘worst
imaginable’’ as upper VAS anchor for these two dimen-
sions. This is analogous to the other three dimensions,
which ranged from ‘‘no problems’’ to ‘‘unable to’’.
Study design
Data collection took place in the form of one of two panel
sessions and a follow-up postal survey 2 weeks later. A
convenience sample of 82 laypeople from an existing
general population panel (N = 560) participated. All par-
ticipants were familiar with the vignette presentation form
used in the indirect method.
All participants completed both the direct and the indi-
rect quantification task. For the direct method, all 3L
answers were obtained during the panel sessions and all 5L
answers as part of the postal survey to avoid memory
effects. For the indirect method, participants scored ten
health states in the panel sessions (acute pharyngitis,
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Table 1 Direct quantification of three- and five- level (3L, 5L) descriptors
Number Mean Median 95% CI
3L
Mobility
No problems in walking abouta – – – –
Some problems in walking about 74 26.70 22 22.82-30.59
Unable to walk abouta – – – –
Self-care
No problems with self-carea – – – –
Some problems washing or dressing self 74 30.18 28 26.10-34.25
Unable to wash or dress selfa – – – –
Usual activities
No problems with performing usual activitiesa – – – –
Some problems with performing usual activities 77 29.74 25 25.95-33.53
Unable to perform usual activitiesa – – – –
Pain/Discomfort
No pain or discomforta – – – –
Moderate pain or discomfort 66 32.33 31 28.56-36.10
Extreme pain or discomfort 66 86.36 89 83.75-88.98
Worst imaginable pain or discomforta – – – –
Anxiety/Depression
Not anxious or depresseda – – – –
Moderately anxious or depressed 67 33.94 34 29.89-37.99
Extremely anxious or depresseda 67 88.82 90 86.88-90.77
Worst imaginable anxiety or depressiona – – – –
5L
Mobility
No problems in walking abouta – – – –
Mild problems in walking about 75 11.31 11 9.73–12.88
Some problems in walking about 75 38.39 40 35.39–41.39
Many problems in walking about 75 79.80 82 76.81–82.79
Unable to walk abouta – – – –
Self-care
No problems with self-carea – – – –
Mild problems washing or dressing self 76 11.24 10 9.72–12.76
Some problems washing or dressing self 76 37.14 38 34.14–40.15
Many problems washing or dressing self 76 80.61 81 77.81–83.40
Unable to wash or dress selfa – – – –
Usual activities
No problems with performing usual activitiesa – – – –
Mild problems with performing usual activities 77 11.08 10 9.29–12.87
Some problems with performing usual activities 77 39.01 40 36.12–41.90
Many problems with performing usual activities 77 80.81 83 77.70–83.91
Unable to perform usual activitiesa – – – –
Pain/Discomfort
No pain or discomforta – – – –
Mild pain or discomfort 53 8.85 8 7.43–10.26
Moderate pain or discomfort 53 32.32 31 29.58–35.06
Severe pain or discomfort 53 67.94 68 64.98–70.90
Extreme pain or discomfort 53 91.26 94 88.96–93.57
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exacerbation of eczema, hip fracture, cerebrovascular
accident/stroke with moderate impairments, moderate
gastritis, low spinal cord lesion, mild depression, back and
neck pain, severe dementia, and acute multiple injury) and
the remaining five in the survey (otitis externa, severe
stable brain injury, irritable bowel syndrome, acute large
burn, and posttraumatic stress disorder), because we
expected that more than ten health states within one session
could lead to concentration problems. The two sets of
health states were balanced according to severity and
duration. Following this design, the indirect method pro-
vided 225 responses for each respondent: 15 diseases 9 5
dimensions 9 3 response scales.
Direct quantification of level descriptors
In the direct method, respondents were asked to project the
3L and the 5L descriptors on the VAS scales for each
dimension separately. As the extreme levels were used as
anchors of the VAS, for 3L only, the midcategory (3L-2)
level descriptor needed to be scored, except for Pain/Dis-
comfort and Anxiety/Depression, which needed additional
scoring of 3L-3 (extreme). Similarly, the midcategories 5L-
2, 5L-3, and 5L-4 descriptors were scored for each
dimension, except for Pain/Discomfort and Anxiety/
Depression, which included the scoring of 5L-5.
Indirect quantification of level descriptors
As an alternative to the direct method, we developed an
indirect method that we believe lies closer to the actual use
of the EQ-5D instrument, as it uses a (hypothetical) health
state as a calibrator or medium to derive a VAS score. In
contrast to the direct method, the object of measurement in
the indirect method is not a 3L or 5L descriptor but a
complete health scenario (vignette). Each vignette was
scored with the 3L and 5L descriptors and on a VAS, one
for each separate dimension, independently. Consequently,
an indirect head-to-head comparison of 3L and 5L scores
could be made, calibrated via the common VAS score.
Figure 1 shows one of the vignettes. Each vignette was
designed to present a disease as close to clinical reality as
possible, therefore also including information on disease
duration. All 15 diseases were presented on a standardized
sheet (vignette) that contained (1) a disease label with a
naturalistic description of the disease; (2) the course of the
disease over a 1-year period using a calendar (the grey
scales represent the duration of the disease); (3) the loca-
tion of the disease with, if relevant, a visual representation;
and (4) the EQ-5D dimensions, of which the levels were
left unspecified, as the respondents were invited to select
the appropriate EQ-5D level (according to his or her own
view) for each dimension. Respondents were asked to read
each vignette carefully and to select the level of each
dimension of the EQ-5D descriptive system that best
described the presented health state in their view using
three response scales: the standard 3L response scale, the
new 5L scale, and the VAS scale (similar to the VAS used
in the direct method).
The 5L and 3L response scales were presented on the
left and the right side of one page (per dimension),
respectively. The respondents were first invited to score the
5L descriptors for all dimensions and all vignettes while
covering the right side of the page that showed the 3L
descriptors. Next, they were instructed to return to the first
vignette, asked to cover the left side with the 5L scores, and
provide the 3L response for all vignettes. Pilot testing
revealed that when respondents scored 3L first, there was a
tendency to avoid the in-between levels 2 and 4 of 5L, and
for this reason, all respondents were asked to score 5L first.
Adequate instruction was critical, stressing that 3L and 5L
were two independent ways of scoring (in the postal sur-
vey, these instructions were repeated in writing).
Subsequently, VAS scores were obtained on a separate
form without respondents having access to the 3L and 5L
scores. The demanding task of first providing 5L
Table 1 continued
Number Mean Median 95% CI
Worst imaginable pain or discomforta – – – –
Anxiety/Depression
Not anxious or depresseda – – – –
A little anxious or depressed 59 9.46 8 7.97–10.94
Moderately anxious or depressed 59 32.56 33 30.01–35.11
Very anxious or depressed 59 67.37 66 64.55–70.20
Extremely anxious or depressed 59 91.34 92 89.42–93.25
Worst imaginable anxiety or depressiona – – – –
CI confidence interval
a Level descriptor used as anchor in visual analog scale
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classifications on all five dimensions of all 15 vignettes
minimized possible memory effects when the participants
were instructed to return to the first vignette to score the 3L
classifications while covering the 5L responses.
Analysis
Results of the direct and indirect methods are presented
with conventional descriptive statistics. Results of the
indirect method were derived by grouping 3L-VAS pairs
and 5L-VAS pairs for each respondent per vignette and
subsequently by calculating level means over all vignettes
and all respondents combined. For each respondent, scor-
ings were removed for the combined 3L, 5L, and VAS
scores if at least one of the 3L, 5L, or VAS scores was
missing, equalizing the number of VAS observations
between 3L and 5L.
Characteristics
For both the direct and indirect methods, the 3L–5L
extension of EQ-5D was investigated in terms of three
characteristics. First, equidistance addresses the degree to
which 3L and 5L level descriptors are distributed evenly
over the VAS continuum, either without or with transfor-
mation. Equidistance is determined for each dimension and
each instrument (3L and 5L) separately. Untransformed
equidistance implies that level descriptors are distributed
according to VAS ratings of 0–50–100 for 3L and 0–25–
50–75–100 for 5L. There is evidence that the precision of
the VAS might be illusory, as respondents mentally divide
the VAS continuum in a smaller number of segments,
which is nine or ten at maximum [23, 24]. Therefore, we
defined a deviation of 5 VAS points as the maximum
acceptable deviation (which makes a segment of 10 VAS
points, as the deviation can be either way). Furthermore, a
deviation of 5 VAS points has been used before [16]. If
untransformed equidistance is rejected, equidistance using
power [y = (ax)b] transformation is considered. A power
relation of, e.g., y = (5.38*x)1.5 for 5L would result in a
VAS rating distribution of 0–12–35–65–100. Note that
transformation is only possible for 5L, as there is only one
3L observation apart from the anchors.
Part of the evaluation of equidistance is analysis of the
position of the extreme levels according to the indirect
method: are the VAS ratings for the extreme level
descriptors close to the supposed anchor values for the
indirect method? Ideally, 3L-1 and 5L-1 scores would
equal 0 and 3L-3 and 5L-5 scores would equal 100, except
for Pain/Discomfort and Anxiety/Depression in which the
3L and 5L extreme level descriptors were not identical to
the VAS anchors.
Second, isoformity is the degree to which the positions
of 3L-2 and 5L-3 level descriptors (and also 3L-3 versus
5L-5 for Pain/Discomfort and Anxiety/Depression) are
similar. Isoformity directly compares the 3L and 5L
descriptive systems for each separate dimension between
instruments. For the indirect method, all 3L level means,
including 3L-1 and 3L-3, can be compared with 5L.
Analysis of isoformity is based on paired 3L–5L response
means for each dimension separately. For the direct
method, isoformity was tested with a paired t test between
the 3L and 5L scorings. For the indirect method, a devia-
tion of 5 VAS points was defined as the maximum
acceptable deviation.
Finally, consistency between dimensions is the degree to
which the positions of the same level descriptors differ
across dimensions. Consistency, between dimensions was
tested for each instrument (3L, 5L) separately. The first
three dimensions (Mobility, Self-Care, and Usual Activi-
ties) were distinguished from the last two (Pain/Discomfort
and Anxiety/Depression), as these—in Dutch—share
identical level descriptors, e.g., some problems for
Mobility, Self-Care, and Usual Activities. For the direct
method, analysis of variance (ANOVA) was used for each
identical level descriptor for the first three dimensions
combined (one comparison for 3L and three for 5L) and
Stroke (CVA, cerebral infarction, cerebral 
accident), after the acute phase, is subdivided 
into disease stages as follows: 
1. mild impairments 
2. moderate impairments 
3. severe impairments 
Value now: 
In what state during the disease ? 
Location of disease ? When is the disease present ? 
january february march april
mo 6 13 20 27 3 10 17 24 3 10 17 24 31 7 14 21 28
tu 7 14 21 28 4 11 18 25 4 11 18 25 1 8 15 22 29
we 1 8 15 22 29 5 12 19 26 5 12 19 26 2 9 16 23 30
th 2 9 16 23 30 6 13 20 27 6 13 20 27 3 10 17 24
fr 3 10 17 24 31 7 14 21 28 7 14 21 28 4 11 18 25
sa 4 11 18 25 1 8 15 22 1 8 15 22 29 5 12 19 26
su 5 12 19 26 2 9 16 23 2 9 16 23 30 6 13 20 27
may june july august
mo 5 12 19 26 2 9 16 23 30 7 14 21 28 4 11 18 25
tu 6 13 20 27 3 10 17 24 1 8 15 22 29 5 12 19 26
we 7 14 21 28 4 11 18 25 2 9 16 23 30 6 13 20 27
th 1 8 15 22 29 5 12 19 26 3 10 17 24 31 7 14 21 28
fr 2 9 16 23 30 6 13 20 27 4 11 18 25 1 8 15 22 29
sa 3 10 17 24 31 7 14 21 28 5 12 19 26 2 9 16 23 30
su 4 11 18 25 1 8 15 22 29 6 13 20 27 3 10 17 24 31
september october november december 
mo 1 8 15 22 29 6 13 20 27 3 10 17 24 1 8 15 22 29
tu 2 9 16 23 30 7 14 21 28 4 11 18 25 2 9 16 23 30
we 3 10 17 24 1 8 15 22 29 5 12 19 26 3 10 17 24 31
th 4 11 18 25 2 9 16 23 30 6 13 20 27 4 11 18 25
fr 5 12 19 26 3 10 17 24 31 7 14 21 28 5 12 19 26
sa 6 13 20 27 4 11 18 25 1 8 15 22 29 6 13 20 27
su 7 14 21 28 5 12 19 26 2 9 16 23 30 7 14 21 28
STROKE (CVA) 
A patient who experiences moderate
impairments after a stroke throughout the 
whole year.
The main symptoms are mild paralyses.  
Also disorders like speech inability (aphasia), 
slow thought/action, memory problems, problems 
with swallowing and incontinence.  
Use the response form, 
it’s your impression that counts, there are 
no right or wrong answers 
   ?   Mobility 
   ?   Self-Care  
   ?   Usual Activities 
   ?   Pain/Discomfort 
   ?   Anxiety/Depression 
Fig. 1 Disease vignette with empty EQ-5D descriptive system
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Pain/Discomfort and Anxiety/Depression combined (two
comparisons for 3L and four for 5L), resulting in a total of
ten comparisons . For the indirect method, consistency is
tested with a generalizability study (G-study). In a G-study,
one is able to separate multiple sources of error variance
[25]. Generalizability coefficients (G-coefficients) can be
constructed as functions of the estimated variance com-
ponents, expressing consistency on a 0–1 scale, with 1
expressing perfect consistency [26, 27]. We used a vari-
ance components analysis based on the restricted
maximum likelihood method and identified four possible
sources of variance: label, vignette, dimension, and
respondent. Four separate G-studies were conducted, one
on the first three dimensions and one on the remaining two
dimensions, for each instrument (3L, 5L) separately. A G-
coefficient expressing consistency between dimensions was
calculated on the basis of these variance components
(‘‘Appendix A’’).
We regarded transformed or untransformed equidistance
to be a desirable characteristic for the new 5L system as
opposed to no systematic relation between the quantitative
position of the level descriptors at all. Consistency between
identical-level descriptors across dimensions was also
regarded as a desirable property because this expresses that
respondents have a consistent conceptualization of the
grading terms used over different dimensions of health.
When consistency is achieved, this does not imply that
utility values would also be expected to be consistent over
dimensions, because utility values are an expression of an
entire EQ-5D profile, whereas we investigated VAS scores
within each dimension separately. Furthermore, a choice-
based method presumably leads to different results than the
dimension-specific VAS scales we used. We investigated
isoformity to see whether the new 5L system was a
refinement or a new system, and whether isoformity was
achieved or not does not tell us anything about the 5L
system in itself.
Results
The mean age of the participants was 53.6 years, with
42.7% being men. Of the 82 respondents who attended in
the panel sessions, 81 returned the survey. Three respon-
dents (4%) were of Turkish nationality, two (2%) were of
Moroccan nationality, and the remaining 75 (94%) were of
Dutch origin. In the Pain/Discomfort and Anxiety/
Depression dimensions, respondents often failed to score
the extreme-level descriptor when using the direct method
(8 and 9 for 3L, respectively, and 22 and 16 for 5L,
respectively). For these respondents, the remaining scor-
ings were deleted for that dimension because of possible
context effects (i.e., spreading out the VAS scores of the
remaining 3L descriptors over the VAS scale). For the
direct method, missing responses for 3L ranged from 6.1%
(Usual Activities) to 19.5% (Pain/Discomfort) and for 5L
from 4.9% (Usual Activities) to 34.6% (Pain/Discomfort).
For the indirect method, missing responses ranged from
1.1% (Usual Activities) to 2.5% (Pain/Discomfort) for the
three response scales (3L, 5L, and VAS) combined.
Characteristics: direct method
Results for the direct method are shown in Table 1 and
Fig. 2. Untransformed equidistance was rejected for all
level descriptors except 5L-4 in Mobility (80), although
Self-Care and Usual Activities were only 1 VAS point
away for Mobility. Regardless of dimension, level
descriptors were positioned systematically lower than the
expected value for equidistance for 3L-2 (16–23 VAS
points lower), 5L-2 (14–16 points lower), and 5L-3 level
(11–18 points lower), whereas 5L-4 was sometimes higher
(4–5 points) and sometimes lower (7–8 points). Trans-
formed equidistance (power function) provided an
excellent fit for all dimensions of 5L (R2 C 0.99).
Isoformity could not be established except for the
middle-level descriptors (3L-2 vs. 5L-3) for Pain/Discom-
fort and Anxiety/Depression (Table 2). Relatively large
gaps appeared between 3L-2 and 5L-3 for Mobility (11),
Self-Care (8), and Usual Activities (9), with 5L-3 showing
systematically higher values. Although there was a statis-
tically significant difference between the extreme level
descriptors (3L-3 vs. 5L-5) for Anxiety/Depression, the
absolute difference was 3 VAS points.
Consistency between dimensions gives supportive
results for both 3L and 5L, as none of the ten comparisons
(ANOVA) showed significant differences (see Fig. 2).
Generally, VAS means are similar among the first three
dimensions as well as among Pain/Discomfort and Anxi-
ety/Depression.
Characteristics: indirect method
Results of the indirect method are shown in Table 3 and
Fig. 3. Untransformed equidistance of 3L-2 was rejected
for all dimensions (systematically 7–14 VAS points too
low) as well as for 5L-2 (systematically 8–13 points lower)
and 5L-3 (systematically 8–17 points lower). Untrans-
formed equidistance was achieved only for the 5L-4 level
for all dimensions (systematically 1–5 points lower), with
VAS scores ranging from 70 (Mobility and Usual Activi-
ties) to 74 (Anxiety/Depression). Transformed equidistance
(power function) provided an excellent fit for all dimen-
sions of 5L (R2 C 0.99).
VAS results for the extreme-level descriptors show that
the lower extreme is close to 0, except for Pain/Discomfort
468 Qual Life Res (2008) 17:463–473
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(3L-1 = 13; 5L-1 = 8). VAS results for the upper extreme
values are systematically higher for 5L than for 3L (range of
difference: 6–10). Noticeable are large deviations in Self-
Care (3L-3 = 85; 5L-5 = 91) and Usual Activities (3L-
3 = 89). Isoformity was accepted for 3L-1 versus 5L-1 for
all dimensions and for 3L-2 vs. 5L-3 for all dimensions
except Mobility (showing a gap of 7 points). Isoformity was
rejected for the upper extreme comparison 3L-3 versus 5L-5
for all dimensions. Consistency between dimensions gave
supportive results for both 3L and 5L. Table 4 shows the
G-study results. Most variance is attributed to the label
component, whereas less than 2% of variance is attributed
to the components including dimension, which is reflected
in high G-coefficients for all comparisons. Consistency for
5L is somewhat higher (0.87; 0.86) than for 3L (0.86; 0.81).
Discussion
In this study, we compared the quantitative position of the
level descriptors of the standard EQ-5D3L and a new five-
level version using two independent methods. The study
showed that the extension of the EQ-5D3L to a five-level
version by inserting two extra levels, leaving the existing
descriptors unaltered, is not a simple refinement but a
redesign. The inserted levels pushed the extreme levels
closer to the anchors, which indicates that 5L makes better
use of the measurement continuum, contributing to supe-
rior descriptive power of the 5L version. In both the 3L and
5L versions, the position of the 3L or 5L descriptors,
reassuringly, was independent of dimension.
Equidistance was not achieved for both systems, in most
cases showing values lower than the equidistant values.
no problems in 
walking about 
unable to 
walk about
no problems  
with self-care
unable to care 
for self 
no problems 
with performing 
usual activities 
unable to 
perform usual 
activities 
no pain or 
discomfort 
worst imaginable 
pain or discomfort 
not anxious or 
depressed
worst imaginable 
anxiety or 
depression
3L-2 
27
11
5L-2 
38
5L-3
80
5L-4 
MOBILITY
3L-2 
30
SELF CARE
3L-2 
30
USUAL ACTIVITIES
3L-2 
32
3L-3 
86
PAIN/DISCOMFORT
3L-2 
34
3L-3 
89
ANXIETY/DEPRESSION
11
5L-2 
37
5L-3
81
5L-4 
11
5L-2 
39
5L-3
81
5L-4 
9
5L-2 
32
5L-3 
68
5L-4
91
5L-5 
9
5L-2 
33
5L-3
67
5L-4
91
5L-5 
n=75
n=74
n=75 n=75
n=76
n=74
n=76 n=76
n=77
n=77
n=77 n=77
n=53
n=66
n=53 n=53 n=53
n=59
n=67
n=59 n=59 n=59
n=66
n=67
Fig. 2 Direct quantification of
the three- and five-level (3L,
5L) descriptors. Visual analog
scale (VAS) means by
dimension
Table 2 Isoformity of identical three-and five-level (3L, 5L)
descriptors for the direct quantification method
Dimension Comparison Mean difference P value
Mobility 3L-2 5L-3 -11.4 \0.001
Self-care 3L-2 5L-3 -8.0 0.002
Usual activities 3L-2 5L-3 -9.4 \0.001
Pain/Discomfort 3L-2 5L-3 -1.4 0.501
Pain/Discomfort 3L-3 5L-5 -4.9 0.012
Anxiety/Depression 3L-2 5L-3 2.8 0.276
Anxiety/Depression 3L-3 5L-5 -3.0 0.025
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Table 3 Indirect quantification of three- and five-level (3L, 5L) descriptors
Number Mean Median CI
3L
Mobility
No problems in walking about 599 1.69 0 1.31–2.07
Some problems in walking about 403 42.94 40 40.24–45.64
Unable to walk about 180 91.70 99 89.28–94.12
Self-care
No problems with self-care 482 3.24 0 2.40–4.08
Some problems washing or dressing self 435 39.18 34 36.58–41.78
Unable to wash or dress self 273 85.47 95 82.77–88.16
Usual activities
No problems with performing usual activities 235 4.50 2 3.49–5.51
Some problems with performing usual activities 582 36.55 30 34.40–38.71
Unable to perform usual activities 378 88.54 95 86.87–90.22
Pain/Discomfort
No pain or discomfort 246 12.64 4 9.94–15.34
Moderate pain or discomfort 643 35.76 31 33.92–37.60
Extreme pain or discomfort 275 83.21 89 80.82–85.61
Anxiety/Depression
Not anxious or depressed 433 6.29 1 5.01–7.57
Moderately anxious or depressed 478 42.45 40 40.26–44.63
Extremely anxious or depressed 270 84.80 90 82.73–86.86
5L
Mobility
No problems in walking about 547 1.30 0 0.92–1.69
Mild problems in walking about 147 15.33 11 12.64–18.02
Some problems in walking about 159 36.48 31 33.00–39.97
Many problems in walking about 217 69.82 76 66.72–72.92
Unable to walk about 112 97.36 100 95.24–99.48
Self-care
No problems with self-care 398 2.45 0 1.43–3.48
Mild problems washing or dressing self 204 12.70 9 10.76–14.64
Some problems washing or dressing self 184 36.09 33 33.00–39.17
Many problems washing or dressing self 257 71.20 78 68.33–74.06
Unable to wash or dress self 147 91.37 99 87.80–94.94
Usual activities
No problems with performing usual activities 136 3.22 0 1.49–4.95
Mild problems with performing usual activities 268 12.39 9 10.68–14.10
Some problems with performing usual activities 228 32.53 30 29.97–35.09
Many problems with performing usual activities 351 69.54 75 67.18–71.90
Unable to perform usual activities 212 95.35 100 93.74–96.96
Pain/Discomfort
No pain or discomfort 145 8.34 0 5.32–11.37
Mild pain or discomfort 274 17.27 12 15.13–19.41
Moderate pain or discomfort 367 36.83 35 34.91–38.76
Severe pain or discomfort 263 71.72 79 69.05–74.39
Extreme pain or discomfort 115 92.76 98 89.86–95.65
Anxiety/Depression
Not anxious or depressed 305 4.75 0 3.07–6.43
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Both methods revealed a large gap between the 5L-3 and
5L-4 levels, regardless of dimension. This could be caused
by the wording of 5L-3 [some and moderate(ly)] being
interpreted as fairly mild.
In Pain/Discomfort, respondents tended to avoid the
lower anchor of the scale, indicating some pain or dis-
comfort on VAS while scoring no problems on 3L and 5L.
This indicates that respondents preferred a more refined
response scale for scoring pain or discomfort, maybe a
scale with even more than five response options (as is the
case of, e.g., the HUI3 or SF-36). Also noticeable were the
gaps observed for the upper extreme in Self-Care, for
which we cannot provide an explanation.
Isoformity between 3L and 5L showed mixed results.
The 3L-1 vs. 5L-1 descriptors showed isoformity (indirect
method only), as expected, as these both indicated the
upper ceiling (no problems). Isoformity was also estab-
lished for the middle level descriptors of Pain/Discomfort
and Anxiety/Depression for both methods. This could be
due to the wording of the middle level descriptors, as the
descriptor some problems represented a wider range and
hence more potential variation, than moderate(ly), as used
in Pain/Discomfort and Anxiety/Depression. Assuming that
the descriptor some problems was a well-considered choice
in the development of the original EQ-5D3L system in
order to cover the entire range between the two extremes, it
is questionable whether that descriptor is still suitable in a
5L version.
Direct quantification is a well-known method of esti-
mating the magnitude of level descriptors or response
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Fig. 3 Indirect quantification of
the three- and five-level (3L,
5L) descriptors. Visual analog
scale (VAS) means by
dimension
Table 3 continued
Number Mean Median CI
A little anxious or depressed 241 16.48 10 14.33–18.63
Moderately anxious or depressed 271 41.98 41 39.72–44.25
Very anxious or depressed 248 74.19 80 71.69–76.70
Extremely anxious or depressed 116 92.33 97 89.61–95.04
CI confidence interval
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labels [16, 17, 28, 29]. This approach, however, ignores the
fact that the VAS values expressed for the level descriptors
did not necessarily reflect the self-report use of such
descriptors (and the use in subsequent valuation studies) in
a similar way, because the valuation of an abstract level
descriptor might lead to different results than self-reported
health. The indirect method is novel: to our knowledge,
this is the first time a quantification of level descriptors
is estimated with this method. The indirect method has
several advantages. First, we believe it is a better repre-
sentation of the hypothesized measurement continuum of
EQ-5D, as the medium of the vignette (disease) was used to
calibrate 3L and 5L descriptors on a VAS scale. Second, it
is closer to the general use of the EQ-5D instrument as a
self-report health status assessment measure and is there-
fore likely to be more valid. Classifying a vignette can be
regarded similarly to a health status classification by proxy
assessment. Other advantages of the indirect method are
analytical: values can be calculated for all level descriptors,
including the anchors, and it is possible to investigate
explained variance for various components (G-study).
Furthermore, the indirect method proved to be much more
feasible than the direct method, considering the lower
number of missing responses. Disadvantages are that no
direct comparison (e.g., paired t test) between 3L and 5L is
possible, as there is only one VAS value for each 3L–5L
response pair, and that the indirect method is more time
consuming.
A potential weakness of the study procedure is that 3L
and 5L were presented on one sheet, and panelists were
asked to score 5L dimensions first while covering 3L and
vice versa. We cannot be sure that respondents actually
complied to the blinding procedure in the follow-up mea-
surement. Also, there might have been an order effect, as
5L always preceded 3L.
The 5L instrument presented here obviously improves
the discriminatory potential of the EQ-5D descriptive
system, as the level descriptors generally capture a larger
part of the measurement continuum and broaden the
measurement space. Furthermore, 5L showed slightly
better consistency between levels. In a previous study, we
demonstrated increased discriminatory power of the same
5L version of EQ-5D, as well as superior reliability
(interobserver and test–retest) and face validity when
compared with the standard EQ-5D3L [18]. Awaiting a
valuation study for an official version of 5L, a set of
preference weights was developed for this 5L version of
EQ-5D using item response theory (IRT) methodology
[30]. An officially sanctioned five-level descriptive system
will become available within a short period [31] and is
expected to be in use alongside the standard three-level
EQ-5D.
The experimental five-level EQ-5D version presented
here is likely to demonstrate a less severe ceiling effect.
Assuming that milder states are more common in the
general population, we expect increased benefit in the
detection of mild problems and in measuring and
monitoring general population health, although the extra
5L-4 level is expected to also lead to better differen-
tiation and detection of more severe health states. The
methodology presented here can be of use in the
development of generic or disease-specific health status
measures.
Acknowledgments This research was funded by the EuroQol
Group. An earlier draft of this paper was presented and discussed at
the 2006 Annual EuroQol Meeting in Barcelona.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
Table 4 Consistency between dimensions for the indirect quantifi-
cation method. Variance components estimates (percentages) and
generalizability coefficients (G-coefficients) for comparable dimen-
sions of three- and five-level (3L, 5L) instruments
3L 5L
Mobility/Self-care/Usual activities
Label 66.12 Label 71.52
Vignette 8.05 Vignette 6.35
Dimension 0.26 Dimension 0.04
Respondent 0.33 Respondent 0.79
Label 9 vignette 5.60 Label 9 vignette 2.91
Label 9 dimension 0.22 Label 9 dimension 0.12
Label 9 respondent 2.20 Label 9 respondent 2.59
Vignette 9 dimension 0.60 Vignette 9 dimension 0.17
Vignette 9 respondent 3.77 Vignette 9 respondent 2.57
Dimension 9 respondent 0.76 Dimension 9 respondent 0.60
Residual 12.09 Residual 12.34
G-coefficient 0.86 G-coefficient 0.87
Pain/Discomfort; Anxiety/Depression
Label 65.25 Label 73.58
Vignette 4.95 Vignette 2.73
Dimension 0.00 Dimension 0.00
Respondent 0.65 Respondent 0.77
Label 9 vignette 1.91 Label 9 vignette 1.02
Label 9 dimension 0.04 Label 9 dimension 0.00
Label 9 respondent 2.96 Label 9 respondent 3.36
Vignette 9 dimension 1.06 Vignette 9 dimension 0.17
Vignette 9 respondent 5.52 Vignette 9 respondent 4.50
Dimension 9 respondent 0.88 Dimension 9 respondent 0.45
Residual 16.78 Residual 13.42
G-coefficient 0.81 G-coefficient 0.86
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Appendix A: Formula used to estimate G-coefficients
Consistency between dimensions
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